Sensitivity pattern of methicillin resistant and methicillin sensitive Staphylococcus aureus isolates, against several antibiotics including tigecycline in Iran: A hospital based study

Pakistan Journal of Medical Sciences

Volumn 25, Issue 3, 2009, Pages 443-446

  Aghazadeh, Mohammad ^a   Rahbar, Mohammad ^b   Monnavar, Mohammad Kabeh ^c   Moghadam, Fatemeh Savaheli ^c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Iranian Reference Health Laboratory   (Iran)

^c MILAD HOSPITAL   (Iran)

Author keywords

Antimicrobial agents; Methicillin Resistance; Staphylococcus aureus; Wound infection

Indexed keywords

ANTIBIOTIC AGENT; CEFOXITIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LINEZOLID; OXACILLIN; PENICILLIN G; RIFAMPICIN; TEICOPLANIN; TIGECYCLINE; VANCOMYCIN;

ADULT; AGED; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DIABETIC FOOT; FEMALE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; SURGICAL WARD; SURGICAL WOUND;

EID: 68149091590     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ikeagwu IJ. Amadi ESand Iroha IR., Antimicrobial sensitivity pattern of Staphlococcus aureus in Abakalki, Nigeria. Pak J Med Sci 2008;24:231-235
2. Lentino JR, Narita M, Yu VL. New antimicrobial agent's therapy for resistant gram-negative cocci. Eur J Clin Microbiol Infect Dis 2008;27:3-15. (Pubitemid 350197870)
3. Bouchillon SK, Johnson BM, Hoban DJ, Johnson JL, Dowzicky MJ, Wu DH, et al. Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centers from 17 countries: the PEARLS study 2001-2002 Int J Antimicrob Agents 2004;24:119-124
4. Rahbar M, Babazadeh H, Zargami N. High methicillin resistance of Staphylococcus aureus in imam Khomeini hospital of Uremia, Iran. Infect Control Hosp Epedemiol 2001;22:196-197
5. Rahbar M, Karamiyar M, Gra-Agaji R. Nasal carriage of Methicillin-resistant Staphylococcus aureus among Healthcare workers of an Iranian hospital. Infect Control Hosp Epedemiol 2003;24:337-423
6. Bouchillon SK, Hoban DJ, Johnson BM, Johnson JL, Hsiung A, Dowzicky MJ. Tigecycline Evaluation and Surveillance Trial (TEST) Group. In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004). Diagn Microbiol Infect Dis 2005;52:173.
7. Souli M, Kontopidou FV, Koratzanis E, Antoniadou A, Giannitsioti E, Evangelopoulou P, et al. In vitro activity of tigecycline against multiple-drug-resistant, including pan-resistant, gram-negative and gram-positive clinical isolates from Greek hospitals Antimicrob Agents Chemother 2006;50:3166.
8. Nickie D. Tigecycline (Tygacil): The first in the glycycline class of antibiotics. Proc (Bayl Univ Med Cent) 2006;19:155-161
9. "Harison LS. Text book of diagnostic microbiology. (Third edition) Mahon CR, Lehman DC, Manselis G (Eds), Saunders Philadelphia, PA, USA. pp 367-381, 2007".
10. Clinical and Laboratory Standards Institute (CLSI) 2006. Performance standards for antimicrobial susceptibility testing; 16th informational supplement M100- S 16 CLSI, USA, Wayne. PA
11. Li F De, Wolf Miller F. Epidemiology, surveillance and control of methicilillin resistant Staphylococcus aureua. An overview. Asian Pac J Trop Med 2008;1:50-55
12. Rahbar M, Yaghoobi, Fattahi A. Comparison of different laboratory methods for detection of Methicillin Resistant Staphylococcus aureus Pak J Med Sci 2006;22:442-445
13. Mehta AP, Rodrigues C, Sheth K, Jani S, Hakimiyan A, Fazalbhoy N. Control of methicillin resistant Staphylococcus aureus in a tertiary care Centre-A five-year study. J Med Microbiol 1998;16:31-34
14. Qureshi AH, Rafi S, Qureshi SM, Ali AM. The current susceptibility patterns of methicillin resistant Staphylococcus aureus to conventional anti Staphylococcus antimicrobials at Rawalpindi. Pak J Med Sci 2004;20:361-364 (Pubitemid 40030255)
15. Appelbaum PC. MRSA, the tip of the iceberg. Clin Microbiol Infect 2006;12 Suppl 2:3-10.
16. Chang S, Sievert DM, Hageman JC. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003;348:1342-2134 (Pubitemid 36384101)
17. Centers for Disease Control and Prevention (CDC) Staphylococcus aureus resistant to vancomycin-United States. MMRW Morb Mortal Wkly Rep 2002;51(26):565-567
18. Meka VG, Pillai SK, Sakoulas G. Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA. J Infect Dis 2004;190:311-317 (Pubitemid 38951971)
19. Weigelt J, Itani K, Stevens D, Lau W, Dryden M, Knirsch C. Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother 2005;49:2260-2266 (Pubitemid 40734452)
20. Lentino JR, Narita M, Yu VL. New antimicrobial agents as therapy for resistant gram-positive cocci. Eur J Clin Microbiol Infect Dis 2008;27:3-15. (Pubitemid 350197870)
21. Sakoulas G, Moellering RC Jr, Eliopoulos GM. Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy Clin Infect Dis 2006;42:Suppl 1:S40-50.